ESG Report

Overview

The report is MEI Pharma's first ESG disclosure and describes its ESG framework across environmental, social impact, human capital, and governance topics. It identifies the Board and Nominating and Governance Committee as responsible for ESG oversight. Highlights include energy-efficient office practices, waste reduction and recycling, a 38% female senior leadership team, approximately 57% female employees, paid volunteer time, and STEM education support.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services